Gene therapy slowed Huntington’s disease progression by 75 percent in a landmark trial, with patients showing improved cognition and mobility three years after treatment.
Gene therapy slowed Huntington’s disease progression by 75 percent in a landmark trial, with patients showing improved cognition and mobility three years after treatment.